Patents by Inventor Kinya Uchihashi

Kinya Uchihashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7354775
    Abstract: A reagent for partially lysing a cell membrane of a red blood cell infected with a malaria parasite, comprising: a first surfactant which has predetermined lysing ability for the red blood cell membrane; and a second surfactant which has weaker lysing ability than that of the first surfactant; wherein the reagent has pH of 5 to 7 and osmotic pressure of 200 to 300 mOsm/kg·H2O; and wherein the reagent partially lyses the malaria infected red blood cell membrane such that a malaria parasite is retained in the red blood cell and fluorescent dye passes through the cell membrane, is disclosed. A reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells, are also disclosed.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: April 8, 2008
    Assignee: Sysmex Corporation
    Inventors: Ayumu Yoshida, Kinya Uchihashi, Yuji Itose, Aya Konishi, Hiromitsu Iizuka
  • Publication number: 20080041140
    Abstract: The present invention is to present a blood analyzer which can prevent an abnormal number of white blood cells caused by the lipid particles or the red blood cells of poor hemolysis from being output. The blood analyzer comprises: first white blood cell number obtaining means; second white blood cell number obtaining means; output means for outputting the number of the white blood cells obtained by the second white blood cell number obtaining means, and determining means for determining whether the number of the white blood cells obtained by the second white blood cell number obtaining means is abnormal, wherein the output means is configured to output the number of the white blood cells obtained by the first white blood cell number obtaining means when the determining means determines that the number of the white blood cells obtained by the second white blood cell number obtaining means is abnormal.
    Type: Application
    Filed: June 28, 2007
    Publication date: February 21, 2008
    Inventors: Kinya Uchihashi, Yoshiro Ikeuchi, Noriyuki Narisada
  • Publication number: 20070020721
    Abstract: A blood analyzing method is described that includes steps of: preparing a measurement sample by hemolyzing red blood cells in a blood specimen, the measurement sample containing particles; irradiating a light on the measurement sample to detect two or more types of optical information reflecting characters of the particles in the measurement sample, thereby acquiring data indicating light intensities of the respective optical information as a particle data associated with each of the particles; counting white blood cells based on the particle data; outputting the result of counting white blood cells; determining whether malarial parasites are present or not based on the particle data; and outputting the result of determining. A blood analyzer also described.
    Type: Application
    Filed: July 21, 2006
    Publication date: January 25, 2007
    Inventors: Ayumu Yoshida, Yuji Itose, Kinya Uchihashi
  • Publication number: 20060223137
    Abstract: A reagent for partially lysing a cell membrane of a red blood cell infected with a malaria parasite, comprising: a first surfactant which has predetermined lysing ability for the red blood cell membrane; and a second surfactant which has weaker lysing ability than that of the first surfactant; wherein the reagent has pH of 5 to 7 and osmotic pressure of 200 to 300 mOsm/kg·H2O; and wherein the reagent partially lyses the malaria infected red blood cell membrane such that a malaria parasite is retained in the red blood cell and fluorescent dye passes through the cell membrane, is disclosed. A reagent for detecting malaria infected red blood cells, and a sample analyzing method for detecting malaria infected red blood cells, are also disclosed.
    Type: Application
    Filed: March 28, 2006
    Publication date: October 5, 2006
    Inventors: Ayumu Yoshida, Kinya Uchihashi, Yuji Itose, Aya Konishi, Hiromitsu Iizuka
  • Patent number: 6225124
    Abstract: Aqueous blood-sample diluting reagent and method of its use for compelling a morphological change in a blood sample to yield an MCV value assayed at elapsed time after the sample is drawn to be consistent within a diagnostically acceptable range with the original, immediate post-drawing MCV value. Selection of a small amount of a predetermined surfactant added within a limited range of concentration, and of a salt for adjusting osmotic pressure of the sample is thereby determined. The blood sample is treated with an anti-coagulant agent immediately post-drawing, and for assay in a particle analyzer at post-drawing elapsed time is diluted with the reagent solution. The reagent has an osmotic pressure (&pgr;) of approximately 150-400 mOsm/kg and a pH of 6.0-8.5. The surfactant is present in a 0.0005% to 0.5% concentration and has a hydrophile-lipophile balance (HLB) of 10-20.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: May 1, 2001
    Assignee: Sysmex Corporation
    Inventors: Berend Houwen, Kinya Uchihashi, Yukio Hamaguchi, Rolf Mast
  • Patent number: 5968832
    Abstract: A reagent for measurement of leukocytes and hemoglobin concentration in the blood includes a cationic surfactant in an amount sufficient to lyse erythrocytes and denature hemoglobin, at least one of the following hemoglobin stabilizers:(a) sulfosalicylic acid, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin,(b) 0.2 to 10.0 g/L of a water-soluble chelating agent having a nitrogen atom and a carboxyl group, and(c) piperazine, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, anda buffer for maintaining pH at 4 to 6.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: October 19, 1999
    Assignee: Sysmex Corporation
    Inventors: Kinya Uchihashi, Yoshiro Ikeuchi, Atsushi Shirakami, Yukio Hamaguchi
  • Patent number: 5618733
    Abstract: A reagent for analyzing leucocytes comprises (a) at least one ionic surfactant, being either a cationic or an amphoteric surfactant, in an amount sufficient for lysing erythrocytes and causing damage to a part of cell membranes of leucocytes; (b) at least one organic compound having a hydrophobic group and an acidic group which has a negative charge in an aqueous solution in an amount sufficient for a preserving leucocyte morphology by combining with a cationic component in leucocytes; (c) a nonionic surfactant; and (d) a buffer for adjusting pH.
    Type: Grant
    Filed: December 20, 1994
    Date of Patent: April 8, 1997
    Assignee: Toa Medical Electronics Co., Ltd.
    Inventors: Takashi Sakata, Takashi Morikawa, Kinya Uchihashi, Tomomi Hashimoto
  • Patent number: RE38131
    Abstract: A reagent for measurement of leukocytes and hemoglobin concentration in the blood includes a cationic surfactant in an amount sufficient to lyse erythrocytes and denature hemoglobin, at least one of the following hemoglobin stabilizers: (a) sulfosalicylic acid, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, (b) 0.2 to 10.0 g/L of a water-soluble chelating agent having a nitrogen atom and a carboxyl group, and (c) piperazine, or its salt, in an amount effective for promoting the conversion of hemoglobin into methemoglobin, and a buffer for maintaining pH at 4 to 6.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: June 3, 2003
    Assignee: Sysmex Corporation
    Inventors: Kinya Uchihashi, Yoshiro Ikeuchi, Atsushi Shirakami, Yukio Hamaguchi